DLK Investment Management, LLC
Source: SEC Form 13F · as of Mar 2026DLK Investment Management, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $23.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$23.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 29,779 | $7.3M |
| AMGNAMGEN INC | 20,370 | $7.2M |
| ABTABBOTT LABORATORIES | 52,857 | $5.4M |
| DGXQuest Diagnostics Incorporated | 5,248 | $1.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 765 | $591K |
| ABBVAbbVie Inc. | 1,946 | $423K |
| MRKMerck & Co., Inc. | 3,502 | $421K |
| RIOTRiot Platforms, Inc. | 25,000 | $309K |
| ELVElevance Health Inc. | 800 | $234K |
| ADCTADC Therapeutics SA | 25,305 | $95K |
| EDITEditas Medicine, Inc. | 16,619 | $41K |
| BDTXBlack Diamond Therapeutics, Inc. | 18,200 | $39K |
| NKTXNkarta, Inc. | 11,320 | $24K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 11,690 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.